Bénédicte Delcoigne

951 total citations
45 papers, 554 citations indexed

About

Bénédicte Delcoigne is a scholar working on Rheumatology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Bénédicte Delcoigne has authored 45 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Rheumatology, 9 papers in Genetics and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Bénédicte Delcoigne's work include Rheumatoid Arthritis Research and Therapies (26 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Systemic Lupus Erythematosus Research (9 papers). Bénédicte Delcoigne is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (26 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Systemic Lupus Erythematosus Research (9 papers). Bénédicte Delcoigne collaborates with scholars based in Sweden, Iceland and Norway. Bénédicte Delcoigne's co-authors include Johan Askling, Thomas Frisell, Daniela Di Giuseppe, Hannah Bower, Ulf Lindström, Elisabet Lindqvist, Saedís Saevarsdóttir, Jon A. Tsai, Zuzanna Michalak and Helena Forsblad‐d’Elia and has published in prestigious journals such as Neurology, Journal of Clinical Epidemiology and Annals of the Rheumatic Diseases.

In The Last Decade

Bénédicte Delcoigne

42 papers receiving 546 citations

Peers

Countries citing papers authored by Bénédicte Delcoigne

Since Specialization

Citations

This map shows the geographic impact of Bénédicte Delcoigne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bénédicte Delcoigne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bénédicte Delcoigne more than expected).

Fields of papers citing papers by Bénédicte Delcoigne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bénédicte Delcoigne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bénédicte Delcoigne. The network helps show where Bénédicte Delcoigne may publish in the future.

Co-authorship network of co-authors of Bénédicte Delcoigne

This figure shows the co-authorship network connecting the top 25 collaborators of Bénédicte Delcoigne. A scholar is included among the top collaborators of Bénédicte Delcoigne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bénédicte Delcoigne. Bénédicte Delcoigne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Incidence, stage and outcome of malignant melanoma, keratinocyte and other cancers in individuals with vitiligo or alopecia: intraindividual or familial risks? 2025 ·British Journal of Dermatology ·Bénédicte Delcoigne, (unknown), Johan Askling	2
2	Glucocorticoid exposure and the risk of serious infections in rheumatoid arthritis: a marginal structural model application 2023 ·Lara D. Veeken ·(unknown), Arvid Sjölander, Bénédicte Delcoigne, Johan Askling, Thomas Frisell	8
3	Disease‐modifying antirheumatic drugs and risk of thyroxine‐treated autoimmune thyroid disease in patients with rheumatoid arthritis 2023 ·Journal of Internal Medicine ·(unknown), Bénédicte Delcoigne, Saedís Saevarsdóttir, Johan Askling	5
4	Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers 2023 ·RMD Open ·Bénédicte Delcoigne, Tine Iskov Kopp, Elizabeth V. Arkema, Karin Hellgren, Sella Aarrestad Provan, Heikki Relas, Kalle Aaltonen, Nina Trokovic, Björn Guðbjörnsson, Gerður Gröndal, Eirik Klami Kristianslund, Jesper Lindhardsen, Lene Dreyer, Johan Askling	2
5	Risk of Psychiatric Disorders in Juvenile Idiopathic Arthritis: Population‐ and Sibling‐Controlled Cohort and Cross‐Sectional Analyses 2023 ·ACR Open Rheumatology ·Bénédicte Delcoigne, AnnaCarin Horne, Johan Reutfors, Johan Askling	5
6	Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden 2023 ·RMD Open ·Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, Bénédicte Delcoigne, Ulf Lindström, Carl Turesson, Katerina Chatzidionysiou, Elisabet Lindqvist, Ann Knight, Helena Forsblad‐d’Elia, Johan Askling	1
7	How does current disease activity in rheumatoid arthritis affect the short-term risk of acute coronary syndrome? A clinical register based study from Sweden and Norway 2023 ·European Journal of Internal Medicine ·Bénédicte Delcoigne, Sella Aarrestad Provan, Eirik Klami Kristianslund, Johan Askling, Lotta Ljung	4
8	Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis 2023 ·RMD Open ·Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, Bénédicte Delcoigne, Johan Askling	11
9	OP0133 DO JAKIS WORK THE BEST AMONG THOSE RA PATIENTS WHERE THEIR SAFETY CONCERNS ARE THE HIGHEST? 2023 ·Annals of the Rheumatic Diseases ·Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, Bénédicte Delcoigne, Johan Askling	1
10	Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme 2023 ·Annals of the Rheumatic Diseases ·Thomas Frisell, Hannah Bower, (unknown), Eva Baecklund, Daniela Di Giuseppe, Bénédicte Delcoigne, Nils Feltelius, Helena Forsblad‐d’Elia, Elisabet Lindqvist, Ulf Lindström, Johan Askling, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	52
11	Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study 2022 ·RMD Open ·René Cordtz, Johan Askling, Bénédicte Delcoigne, Karin E. Smedby, Eva Baecklund, Christine Ballegaard, Pia Isomäki, Kalle Aaltonen, Björn Guðbjörnsson, Þorvarður Jón Löve, Sella Aarrestad Provan, Brigitte Michelsen, Joseph Sexton, Lene Dreyer, Karin Hellgren	2
12	Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration 2022 ·Lara D. Veeken ·Bénédicte Delcoigne, Sella Aarrestad Provan, Hilde Berner Hammer, Daniela Di Giuseppe, Thomas Frisell, Bente Glintborg, Gerður Gröndal, Björn Guðbjörnsson, Merete Lund Hetland, Brigitte Michelsen, Dan Nordström, Heikki Relas, Johan Askling	4
13	POS0637 SAFETY OF b/tsDMARDs FOR RA AS USED IN CLINICAL PRACTICE - RESULTS FROM THE LAST DECADE OF THE ARTIS PROGRAM 2022 ·Annals of the Rheumatic Diseases ·Thomas Frisell, Hannah Bower, Eva Baecklund, Daniela Di Giuseppe, Bénédicte Delcoigne, Nils Feltelius, (unknown), Elisabet Lindqvist, Ulf Lindström, Johan Askling	2
14	Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis 2022 ·Annals of the Rheumatic Diseases ·(unknown), Hannah Bower, Thomas Frisell, Bénédicte Delcoigne, Daniela Di Giuseppe, Johan Askling, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	62
15	POS1169 IMPACT OF THE COVID-19 PANDEMIC ON MORBIDITY AND MORTALITY AMONG SWEDISH PATIENTS WITH INFLAMMATORY JOINT DISEASES VERSUS THE GENERAL POPULATION 2021 ·Annals of the Rheumatic Diseases ·Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, Bénédicte Delcoigne, Gerd-Marie Alenius, Eva Baecklund, Katerina Chatzidionysiou, Nils Feltelius, Helena Forsblad‐d’Elia, Alf Kastbom, Lars Klareskog, Elisabet Lindqvist, Ulf Lindström, Carl Turesson, Christopher Sjöwall, Johan Askling	1
16	Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study 2021 ·Annals of the Rheumatic Diseases ·Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, Bénédicte Delcoigne, (unknown), Eva Baecklund, Katerina Chatzidionysiou, Nils Feltelius, Helena Forsblad‐d’Elia, Alf Kastbom, Lars Klareskog, Elisabet Lindqvist, Ulf Lindström, Carl Turesson, Christopher Sjöwall, Johan Askling	56
17	Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors – a Nordic cohort study 2020 ·Lara D. Veeken ·Karin Hellgren, Christine Ballegaard, Bénédicte Delcoigne, René Cordtz, Dan Nordström, Kalle Aaltonen, Björn Guðbjörnsson, Þorvarður Jón Löve, Sella Aarrestad Provan, Joe Sexton, Kristian Zobbe, Lars Erik Kristensen, Johan Askling, Lene Dreyer	9
18	How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers 2020 ·RMD Open ·Katerina Chatzidionysiou, Bénédicte Delcoigne, Thomas Frisell, Merete Lund Hetland, Bente Glintborg, Lene Dreyer, René Cordtz, Kristian Zobbe, Dan Nordström, Nina Trokovic, Kalle Aaltonen, Sella Aarrestad Provan, Gerður Gröndal, Björn Guðbjörnsson, Johan Askling	10
19	Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden 2020 ·Annals of the Rheumatic Diseases ·Tine Iskov Kopp, Bénédicte Delcoigne, Elizabeth V. Arkema, Rikke Kart Jacobsen, Melinda Magyari, Else Helene Ibfelt, Henning Locht, Finn Sellebjerg, René Cordtz, Dorte Vendelbo Jensen, Johan Askling, Lene Dreyer	36
20	Breaking the matching in nested case–control data offered several advantages for risk estimation 2016 ·Journal of Clinical Epidemiology ·Bénédicte Delcoigne, Edoardo Colzani, Michaela Prochazka, Giovanna Gagliardi, Per Hall, Michał Abrahamowicz, Kamila Czene, Marie Reilly	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact